High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
FY2025Q4
FY2026Q1
738.05M
+14.27%
0.505
+32.89%
893.60M
+9.99%
0.980
+25.64%
775.59M
+20.59%
0.847
+51.19%
Estimates Revision
The market is revising Upward the revenue expectations for Lazard, Inc. (LAZ) for FY2025, with the revenue forecasts being adjusted by 5.34% over the past three months. During the same period, the stock price has changed by 19.26%.
Revenue Estimates for FY2025
Revise Upward
+5.34%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
+13%
In Past 3 Month
Stock Price
Go Up
+19.26%
In Past 3 Month
5 Analyst Rating
0Wall Street analysts forecast LAZ stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for LAZ is 50.80 USD with a low forecast of 40.00 USD and a high forecast of 60.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
2 Hold
2 Sell
Hold
0Current: 51.280
Low
40.00
Averages
50.80
High
60.00
0Current: 51.280
Low
40.00
Averages
50.80
High
60.00
Keefe Bruyette
Market Perform
maintain
$57 -> $60
2025-07-25
Reason
Keefe Bruyette
Price Target
$57 -> $60
2025-07-25
maintain
Market Perform
Reason
Keefe Bruyette raised the firm's price target on Lazard to $60 from $57 and keeps a Market Perform rating on the shares.
Wells Fargo
Equal Weight
maintain
$50 -> $52
2025-07-15
Reason
Wells Fargo
Price Target
$50 -> $52
2025-07-15
maintain
Equal Weight
Reason
Wells Fargo raised the firm's price target on Lazard to $52 from $50 and keeps an Equal Weight rating on the shares. The firm's update reflects final reported Q2 EOP assets under management. Based on this update, Wells' Q2 EPS moves to 35c from 34c, 2025 EPS moves to $2.15 from $2.10, and its 2026 and 2027 EPS estimates increase by 10c each to $4.10 and $4.60, respectively.
Citizens JMP
Devin Ryan
Outperform
maintain
$55 -> $60
2025-07-14
Reason
Citizens JMP
Devin Ryan
Price Target
$55 -> $60
2025-07-14
maintain
Outperform
Reason
Citizens JMP analyst Devin Ryan raised the firm's price target on Lazard to $60 from $55 and keeps an Outperform rating on the shares. The firm is bullish on the business outlook across Financial Services and FinTech, with capital markets recovering solidly with M&A activity still on a "normalization" tracking up 20% over the first half of last year and is annualizing $4.3T, while the IPO market is also restarting after a more than three-year hiatus with the number of U.S. IPOs up 80% year over year, the analyst tells investors in a research note. Key trends around areas like fundraising, capital deployment, and investment performance remain healthy, but the second half of 2025 is set to be one of the more active periods for the industry since the prior upcycle in 2H20 and 2021, the firm says.
Keefe Bruyette
Market Perform
maintain
$46 -> $57
2025-07-13
Reason
Keefe Bruyette
Price Target
$46 -> $57
2025-07-13
maintain
Market Perform
Reason
Keefe Bruyette raised the firm's price target on Lazard to $57 from $46 and keeps a Market Perform rating on the shares following a transfer of coverage. The firm believes the merger and acquisition environment should continue to improve gradually throughout the second half of the year. While policy and geopolitical uncertainty remain a risk, deal pipelines are still near all-time highs, the analyst tells investors in a research note.
Morgan Stanley
Underweight
maintain
$33 -> $45
2025-06-23
Reason
Morgan Stanley
Price Target
$33 -> $45
2025-06-23
maintain
Underweight
Reason
Morgan Stanley raised the firm's price target on Lazard to $45 from $33 and keeps an Underweight rating on the shares. The firm, which raised its Midcap Advisors Industry View to In-Line due to improving market conditions for dealmaking, expects the pipeline to start moving again, driven by rapidly improving market conditions, regulatory clarity, significant pent-up demand, and structural drivers of M&A, the analyst tells investors in a group note.
Keefe Bruyette
Keefe Bruyette
Market Perform
maintain
$44 -> $46
2025-05-12
Reason
Keefe Bruyette
Keefe Bruyette
Price Target
$44 -> $46
2025-05-12
maintain
Market Perform
Reason
Keefe Bruyette raised the firm's price target on Lazard to $46 from $44 and keeps a Market Perform rating on the shares. Messaging was relatively consistent across the industry as the recent market volatility has led to a slowdown in completed deals, but management teams remain upbeat, the analyst tells investors in a research note.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Lazard Inc (LAZ.N) is 16.37, compared to its 5-year average forward P/E of 16.31. For a more detailed relative valuation and DCF analysis to assess Lazard Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Fair
5Y Average PE
16.31
Current PE
16.37
Overvalued PE
30.69
Undervalued PE
1.94
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
Undervalued EV/EBITDA
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Fair
5Y Average PS
1.36
Current PS
1.51
Overvalued PS
1.56
Undervalued PS
1.15
Financials
Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
LAZ News & Events
Events Timeline
(ET)
2025-07-24
06:34:53
Lazard reports Q2 adjusted EPS 52c, consensus 40c
2025-07-11 (ET)
2025-07-11
06:48:35
Lazard reports $248.4B assets under management as of June 30
2025-06-10 (ET)
2025-06-10
06:48:30
Lazard reports preliminary AUM $235.3B as of May 31
Sign Up For More Events
Sign Up For More Events
News
Preview
8.5
08-02NewsfilterLazard Announces Closing of Senior Notes Offering by Lazard Group LLC
Preview
8.5
08-02NewsfilterLazard Announces Total Consideration for Lazard Group LLC's Cash Tender Offer for Its 3.625% Senior Notes Due 2027
Preview
8.5
07-29NASDAQ.COMLazard Launches Senior Notes Offering And Tender Offer For 2027 Notes
Sign Up For More News
People Also Watch
FAQ
What is Lazard Inc (LAZ) stock price today?
What is Lazard Inc (LAZ)'s business?
What is the price predicton of LAZ Stock?
What is Lazard Inc (LAZ)'s revenue for the last quarter?
What is Lazard Inc (LAZ)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Lazard Inc (LAZ)'s fundamentals?
How many employees does Lazard Inc (LAZ). have?